HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Unconjugated bilirubin inhibits proteolytic cleavage of von Willebrand factor by ADAMTS13 protease.

AbstractBACKGROUND:
Bilirubin is a yellow breakdown product of heme catabolism. Increased serum levels of unconjugated bilirubin are conditions commonly seen in premature neonates and adults with acute hemolysis including thrombotic microangiopathy. Previous studies have shown that unconjugated bilirubin lowers plasma ADAMTS13 activity, but the mechanism is not fully understood.
OBJECTIVES:
The study is to determine whether unconjugated bilirubin directly inhibits the cleavage of von Willebrand factor (VWF) and its analogs by ADAMTS13.
METHODS:
Fluorogenic, surface-enhanced laser desorption/ionization time-of-flight mass spectrometric assay, and Western blotting analyses were used to address this question.
RESULTS:
Unconjugated bilirubin inhibits the cleavage of F485-rVWF73-H, D633-rVWF73-H, and GST-rVWF71-11K by ADAMTS13 in a concentration-dependent manner with a half-maximal inhibitory concentration of ~13, ~70, and ~17 μmol L(-1) , respectively. Unconjugated bilirubin also dose-dependently inhibits the cleavage of multimeric VWF by ADAMTS13 under denaturing conditions. The inhibitory activity of bilirubin on the cleavage of D633-rVWF73-H and multimeric VWF, but not F485-rVWF73-H, was eliminated after incubation with bilirubin oxidase that converts bilirubin to biliverdin. Furthermore, plasma ADAMTS13 activity in patients with hyperbilirubinemia increased after treatment with bilirubin oxidase.
CONCLUSIONS:
Unconjugated bilirubin directly inhibits ADAMTS13's ability to cleave both peptidyl and native VWF substrates in addition to its interference with certain fluorogenic assays. Our findings may help proper interpretation of ADAMTS13 results under pathological conditions. Whether elevated serum unconjugated bilirubin has prothrombotic effect in vivo remains to be determined in our future study.
AuthorsR-N Lu, S Yang, H M Wu, X L Zheng
JournalJournal of thrombosis and haemostasis : JTH (J Thromb Haemost) Vol. 13 Issue 6 Pg. 1064-72 (Jun 2015) ISSN: 1538-7836 [Electronic] England
PMID25782102 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2015 International Society on Thrombosis and Haemostasis.
Chemical References
  • Protease Inhibitors
  • von Willebrand Factor
  • Oxidoreductases Acting on CH-CH Group Donors
  • bilirubin oxidase
  • ADAM Proteins
  • ADAMTS13 Protein
  • ADAMTS13 protein, human
  • Bilirubin
Topics
  • ADAM Proteins (antagonists & inhibitors, blood, metabolism)
  • ADAMTS13 Protein
  • Bilirubin (blood, metabolism, pharmacology)
  • Blotting, Western
  • Dose-Response Relationship, Drug
  • Humans
  • Hyperbilirubinemia (blood, diagnosis, enzymology)
  • Oxidoreductases Acting on CH-CH Group Donors (metabolism)
  • Protease Inhibitors (blood, metabolism, pharmacology)
  • Proteolysis
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • von Willebrand Factor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: